Outpatient Treatment options when Monoclonal Abs and Remdesivir Infusions are in short supply or not accessible

1/18/2022 REVISED: REQUEST FOR CONSIDERATION FOR APPROVAL BY THE CDC and NIH. ?(AWAITING A RESPONSE TO MY REQUEST)

A short course of a weak steroid, prednisone, along with a prophylactic antibiotic, and in some depending upon the degree of shortness of breath, an inhaler that widens our air tubes making it easier to cough up and spit up mucus and virus has been used by physicians to successfully treat appropriate COVID-19 patients infected with this virus who are symptomatic with progressive respiratory symptoms not resolving on their own after a couple of days, to prevent progression to Covid Pneumonias requiring hospitalization. Of course each patient has be be evaluated individually, however many of us healthcare providers have had success in treating many patients using these meds. The CDC approved using steroids (dexamethasone, 6xs stronger than prednisone) in severely compromised hospitalized patients, however from what I'm seeing the majority of hospitalized patients are all empirically being given steroids as doctors are observing that even less compromised patients are benefiting from receiving steroids which appear to be working to both halt and prevent the harm that this Covid 19 Virus to individuals. Covid 19 harms us by inflaming human tissue to a degree well beyond our bodies normal protective immune inflammatory response, by initiating a heightened degree of inflammation that is destructive and life threatening. I'm seeing more and more physicians prescribing steroids, both prednisone and the more potent dexamethasone to patients seen in ERs who are not requiring admission or supplemental oxygen. I've observed that ER (ED) physicians have come to recognize certain 'symptoms' as 'signs' signaling that a patient, if not prescribed steroids, is at extremely high risk of decompensating, signs indicating that this virus is progressing in these patients who are very close to requiring hospitalization and supplemental oxygen. With two years experience under their belts, I see that more and more doctors have empirically observed that steroids when prescribed to patients with signs of impending decompensation, benefit greatly, by being given a dose of steroids during a visit to the ER with an Rx for home use with steps taken by the ER physician to ensure that these patients receive close and continuous follow-up care by the ER physician communicating this to the patient's Primary Care Physician upon discharge from the ER.

As recommended by the CDC and other experts , each and every patient has to be evaluated on an individual basis. There can be no one set of rules applicable to treating a Novel (NEW) virus that is attacking us in so many different ways, with many unknowns yet to be discovered, as scientists throughout the world, our health experts and practicing physicians attempt to devise methods to protect us from harm from this virus. We've used medications once recommended by our healthcare experts such as the CDC, NIH only later to be found to be useless, and to this day we are still testing other methods that we hope to prove to be successful in treating this new virus that we all, with good intention, are still. two years into this Pandemic, still trying to figure out. We've used different vaccines with emergency FDA approval as this unknown has created a Public Health Emergency, with Scientists still working to identify and protect us by developing new vaccines and boosters to prevent the different variants of this virus that continue to emerge from causing us more harm.

Let’s hope the CDC approves or at least acknowledges the efficacy of a cost effective treatment regimen that I’ve been talking about since the start of this pandemic, that has saved so many lives and so many hospitalizations in patients presenting with symptoms that serve as signals tht these patients are at risk of decompensating. Jesus, from a cost effective point of view alone, the protocol I’ve used and recommended since the start of this pandemic deserves more attention; the use of a short course of prednisone along with a generic broad-spectrum antibiotic amounts to less than $20 and has proved, in my experience, to be effective, in appropriate patients that of course have to be evaluated on an individual basis with a set of criteria (symptoms) that deserve recognition as being signs that these patients need to be treated with more cost effective available meds that we practicing physicians have observed to be useful in preventing so many hospitalizations and deaths. I'm asking the CDC to recognize that the majority. if not all of hospitalized Covid 19 infected patients who require and receive supplemental oxygen along with combination of oral and intravenous medications and sometimes intubation, often present as outpatients requesting treatment from doctors such as myself, who have come to recognize symptoms and signs which we have learned by having two years experience in treating this virus, are signs we cn identify and recognize that in certain patients, although not requiring hospitalization and supplemental oxygen, that this virus is advancing in these patients and it's progression can, in many patients be stopped in it's tracks by use of a short course of low dose steroids and a prophylactic broad spectrum antibiotic at a cost of about $20 antibiotic. We physicians who have been treating this virus can recognize those individuals at risk for what we've called "crashing" or decompensating all of a sudden without apparent cause, some requiring intubation, many if not the majority of all who in whom the progression of this disease could have been prevented by early therapeutic intervention who presented with symptoms of fever, chills, chest tightness, slight shortness of breath, compensating by deeper breathing and rest which often masks an underlying or impending hypoxemia. There are many physicians using these meds to treat their patients with close outpatient follow-up and supervision, prescribed by evaluation of individuals in whom we recognize progression of Covid 19 symptoms requiring intervention using all available therapeutic means, especially when monoclonol antibodies are in short supply as well as other recommended therapeutics such a Remdesivir, an intravenous anti-viral infusion not readily accessible to many, etc , a protocol I've requested the CDC consider approving since the start of this Pandemic.